104 related articles for article (PubMed ID: 2059393)
1. Microalbuminuria in patients with essential hypertension. Effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker.
Bianchi S; Bigazzi R; Baldari G; Campese VM
Am J Hypertens; 1991 Apr; 4(4 Pt 1):291-6. PubMed ID: 2059393
[TBL] [Abstract][Full Text] [Related]
2. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G
Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521
[TBL] [Abstract][Full Text] [Related]
3. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
Piñol C; Cobos A; Cases A; Esmatges E; Soler J; Closas J; Pascual R; Planas J
Kidney Int Suppl; 1996 Jun; 55():S85-7. PubMed ID: 8743519
[TBL] [Abstract][Full Text] [Related]
4. Effect of combination therapy with a calcium channel blocker and an angiotensin-converting enzyme inhibitor on renal hypertrophy and urinary albumin excretion in diabetic rats.
Nielsen B; Grønbaek H; Osterby R; Flyvbjerg A
Exp Diabesity Res; 2003; 4(3):191-9. PubMed ID: 15061647
[TBL] [Abstract][Full Text] [Related]
5. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.
Nielsen S; Dollerup J; Nielsen B; Jensen HA; Mogensen CE
Nephrol Dial Transplant; 1997; 12 Suppl 2():19-23. PubMed ID: 9269694
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the effects of nitrendipine and enalapril in essential hypertension.
Verkaaik R; Hogewind BL; Woittiez AJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S63-6. PubMed ID: 1723460
[TBL] [Abstract][Full Text] [Related]
7. Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.
Galceran J; Plana J; Felip A; Pou G; Vila J; Sobrino J
Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):751-7. PubMed ID: 20528630
[TBL] [Abstract][Full Text] [Related]
8. Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs.
Bianchi S; Bigazzi R; Baldari G; Campese VM
Am J Med; 1992 Nov; 93(5):525-8. PubMed ID: 1442855
[TBL] [Abstract][Full Text] [Related]
9. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
[TBL] [Abstract][Full Text] [Related]
10. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].
Durruty P; Tapia JC; Ugarte C; Pérez E; Krause P; Soto N; García de los Ríos M
Rev Med Chil; 1996 Sep; 124(9):1036-44. PubMed ID: 9197016
[TBL] [Abstract][Full Text] [Related]
11. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
[TBL] [Abstract][Full Text] [Related]
12. Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.
Pascual JM; Rodilla E; Miralles A; Gonzalez C; Redon J
J Hypertens; 2006 Nov; 24(11):2277-84. PubMed ID: 17053551
[TBL] [Abstract][Full Text] [Related]
13. [Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril].
Toblli JE; Bellido CA; Iavícoli OR; Costa M; Forcada P; Piñeiro DJ; Lerman J
Medicina (B Aires); 2002; 62(6):544-50. PubMed ID: 12532688
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension.
Bigazzi R; Bianchi S; Baldari D; Sgherri G; Baldari G; Campese VM
Am J Hypertens; 1993 Feb; 6(2):108-13. PubMed ID: 8471229
[TBL] [Abstract][Full Text] [Related]
15. Effects of lisinopril and nitrendipine on urinary albumin excretion and renal function in patients with mild to moderate essential hypertension.
Ogawa Y; Haneda T; Hirayama T; Ide H; Obara A; Maruyama J; Morimoto H; Tanaka H; Kato J; Hayakawa T; Hasebe N; Kikuchi K
Hypertens Res; 2000 Nov; 23(6):607-12. PubMed ID: 11131273
[TBL] [Abstract][Full Text] [Related]
16. [Enalapril in patients with diabetes mellitus type I with microalbuminuria without hypertension].
Semetkowska-Jurkiewicz E; Milewski J; Krupa-Wojciechowska B; Wójcikowski C; Horoszek-Maziarz S
Pol Tyg Lek; 1993 Jan 4-11; 48(1-2):19-21, 26. PubMed ID: 8361875
[TBL] [Abstract][Full Text] [Related]
17. Microalbuminuria and hypertension.
Reboldi G; Gentile G; Angeli F; Verdecchia P
Minerva Med; 2005 Aug; 96(4):261-75. PubMed ID: 16179893
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study.
Marin P; Julve R; Chaves FJ; Giner V; Pascual JM; Armengod ME; Redon J
J Hum Hypertens; 2004 Jan; 18(1):25-31. PubMed ID: 14688807
[TBL] [Abstract][Full Text] [Related]
20. Microalbuminuria as a marker of cardiac damage in essential hypertension.
Mettimano M; Specchia ML; Migneco A; Savi L
Eur Rev Med Pharmacol Sci; 2001; 5(1):31-6. PubMed ID: 11860221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
